| Name | Manor At Perrysburg |
|---|---|
| Location | 250 Manor Drive, Perrysburg, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 75.75% |
| Medicare ID (CCN) | 366022 |
| Legal Business Name | Hcf Of Perrysburg, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1982618963 |
| Organization Name | HCF OF PERRYSBURG, INC. |
| Doing Business As | THE MANOR AT PERRYSBURG |
| Address | 250 Manor Dr, Perrysburg, OH 43551 |
| Phone Number | 419-874-0306 |
News Archive
A sedentary lifestyle can cause an impairment of the transport of blood around the body, which increases the risk of disease in the heart and blood vessels.
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A sedentary lifestyle can cause an impairment of the transport of blood around the body, which increases the risk of disease in the heart and blood vessels.
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.14 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.12 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 70.09 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.63 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.03 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.2 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.54 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 41.62 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.51 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.94 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.18 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.52 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.45 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 61.81 | 82.93 |
News Archive
A sedentary lifestyle can cause an impairment of the transport of blood around the body, which increases the risk of disease in the heart and blood vessels.
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
› Verified 8 days ago
Promedica Skilled Nursing & Rehab Perrysburg Location: 10540 Fremont Pike Rd, Perrysburg, Ohio 43551 Phone: (419) 874-3578 | |
Skld Perrysburg Illuminate Hc Perrysburg Location: 28546 Starbright Blvd, Perrysburg, Ohio 43551 Phone: (419) 666-0935 | |
Avalon By Otterbein At Perrysburg Location: 3525 - 3533 Rivers Edge Drive, Perrysburg, Ohio 43551 Phone: (419) 874-2428 | |
Kingston Rehabilitation Of Perrysburg Location: 345 East Boundary Street, Perrysburg, Ohio 43551 Phone: (419) 873-6100 | |